Many of autoimmune therapiesfocus on reduction of IL-17 and Th17 functions.Here, we demonstrated an efficient method forreduction of IL-17 in an EAE mice model of MS.The therapeutic advantages of WJSCs and IL-4,LIF, and IL-10 anti-inflammatory cytokines mayenable us to develop an effective approach toovercome MS. The gene discussed is LIF; the disease is myeloid sarcoma.